Marco Coutinho da Silva, DVM, MS, PhD, Diplomate ACT, associate professor-clinical of theriogenology and reproductive medicine in OSU's Department of Veterinary Clinical Sciences, and Dr. John Lannutti, professor of Materials Science and Engineering in the College of Engineering, are collaborating in an effort to curb the overpopulation of wild horses and burros in the United States, thanks to an $800,000 grant from the U.S. Department of the Interior’s Bureau of Land Management (BLM).
Wild horses and burros (WH&B) can be found roaming free in many western states. The animals have been federally protected since 1971 as part of the Free-Roaming Horses and Burros Act, which declares the animals “living symbols of the historic and pioneer spirit of the west.”
On May 11, 2016, the BLM released new statistics on the wild horse and burro population. In 1971, there were 25,000 WH&B on U.S. lands. Over the past few decades, the WH&B population has surged to an unprecedented 67,000, which is 40,000 more than the BLM’s Acceptable Management Level of 27,000 at which wildlife and livestock can live in balance with the animals.
Currently, the animals are rounded up every three years and given various treatments, one being a contraceptive. The contraceptive is in the form of a vaccine that contains porcine zona pellucida (PZP), which inhibits pregnancy by stimulating the creation of antibodies that prevent sperm from attaching to eggs.
Although the PZP vaccine works as it’s supposed to, it hasn’t been totally effective in hindering WH&B population growth. One issue could be the drug’s instant release form, which may wear off long before the females are re-vaccinated. This hypothesis led the BLM to look to researchers who can redesign how it is delivered once inside the body.
Using a novel nanoscale production method, Coutinho da Silva and Lannutti are developing a tiny capsule that will allow the contraceptive to survive and function in WH&B for three years or longer, reducing the birth rate and eliminating the need for extra round-ups.
“It’s basically a carrier that we can design with different properties to release the vaccine at predetermined time periods,” Coutinho da Silva said. “The goal is to provide timed boosting mechanisms without the need for us to physically go and give the horses an injection.”
The challenge the researchers face during testing is to accurately mimic the biomechanical pressures their capsule will undergo once it’s placed inside the animal. They will do this by using a specialized machine that exposes the capsule to specific levels of tension and compression at intervals that simulate the behavior of WH&B in the wild.
Coutinho da Silva and Lannutti begin biomechanical testing this month, and if their design proves successful they will move to several live-animal models.
“If the outcome of the planned extensive animal testing is efficacious, the next step will be to generate a more proficient delivery system, potentially being able to dart animals from helicopters,” Coutinho da Silva said, adding that this would lessen the labor and monetary burdens involved in supporting current WH&B contraceptive initiatives.